---
title: "Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285995344.md"
description: "On May 1, 2026, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) based in Conshohocken, Pennsylvania, disclosed that it provided equity awards to 47 recently hired non-executive staff as inducement awards under the 2025 Inducement Plan. These awards were sanctioned by Madrigal's autonomous Compensation Committee following Nasdaq Listing Rule 5635(c)(4) guidelines. Madrigal focuses on creating innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH)."
datetime: "2026-05-11T20:31:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285995344.md)
  - [en](https://longbridge.com/en/news/285995344.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285995344.md)
---

# Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

On May 1, 2026, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) based in Conshohocken, Pennsylvania, disclosed that it provided equity awards to 47 recently hired non-executive staff as inducement awards under the 2025 Inducement Plan. These awards were sanctioned by Madrigal's autonomous Compensation Committee following Nasdaq Listing Rule 5635(c)(4) guidelines. Madrigal focuses on creating innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH).

### Related Stocks

- [MDGL.US](https://longbridge.com/en/quote/MDGL.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders](https://longbridge.com/en/news/286674743.md)
- [UBS Group AG Trims Position in Madrigal Pharmaceuticals, Inc. $MDGL](https://longbridge.com/en/news/285205539.md)
- [Clearmind Medicine Announces 1-for-10 Reverse Stock Split; Stock Down](https://longbridge.com/en/news/286961923.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital | QNTM Stock News](https://longbridge.com/en/news/286727225.md)